Table 2. Basic characteristics of study participants with respect to outcome.
Characteristics | Total patients N (%) | Outcome | p-value | |
Alive , N=59 (%) | Died, N=9 (%) | |||
Demographics | ||||
Age (years) ≤48 | 33/68 (49) | 30 (51) | 3 (33) | 0.47 |
>48 | 35/68 (51) | 29 (49) | 6 (67) | |
Gender, Males | 43/68 (63) | 36 (61) | 7 (78) | 0.46 |
Females | 25/68 (29) | 23 (39) | 2 (22) | |
Symptoms | ||||
Fever | 57/68 (84) | 48 (81) | 9 (100) | 0.33 |
Cough | 40/68 (59) | 34 (58) | 6 (67) | 0.72 |
Dyspnoea | 28/68 (41) | 21 (36) | 7 (78) | 0.02* |
Headache/myalgia | 14/68 (21) | 11 (19) | 3 (33) | 0.37 |
Running nose | 8/68 (12) | 5 (8) | 3 (33) | 0.06 |
Sore throat | 6/68 (9) | 5 (8) | 1 (11) | 1.0 |
Diarrhoea | 4/68 (6) | 4 (7) | 0 | 1.0 |
Anosmia | 2/68 (3) | 2 (3) | 0 | 1.0 |
Comorbidities | ||||
Hypertension | 15/68 (22) | 10 (17) | 5 (56) | 0.02* |
Diabetes Mellitus | 14/68 (21) | 9 (15) | 5 (56) | 0.01* |
Coronary artery disease | 7/68 (10) | 5 (8) | 2 (22) | 0.2 |
COPD | 3/68 (4) | 0 | 3 (33) | 0.002* |
Hypothyroidism | 2/68 (3) | 4 (7) | 0 | 1.0 |
Asthma | 2/68 (3) | 2 (3) | 0 | 1.0 |
Seizure disorder | 2/68 (3) | 2 (3) | 0 | 1.0 |
Chronic kidney disease | 2/68 (3) | 1 (2) | 1 (11) | 0.24 |
Tuberculosis | 2/68 (3) | 1 (2) | 1 (11) | 0.24 |
Hyperthyroidism | 1/68 (1) | 1 (2) | 0 | 1.0 |
Depression | 1/68 (1) | 1(2) | 0 | 1.0 |